Does Coexistence of Non-alcoholic Fatty Liver Disease and Type-2 Diabetes Impact Weight Loss or Remission of Type 2 Diabetes after Gastric Bypass?

Background: Obesity and type-2 diabetes (T2D) are risk factors for non-alcoholic fatty liver disease (NAFLD), and Gastric Bypass (RYGB) is an effective treatment for obesity, T2D and NAFLD. While 78% of patients of white race with obesity and T2D have coexisting NAFLD, individuals of black race have been found to have a significantly lower prevalence of NALFD (34%, p
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research